Literature DB >> 6817075

Sexually transmitted diseases treatment guidelines 1982.

.   

Abstract

Mesh:

Year:  1982        PMID: 6817075

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


× No keyword cloud information.
  6 in total

Review 1.  Preventing complications of sexually transmitted disease. New treatment guidelines for an expanded spectrum of problems.

Authors:  A E Washington
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

2.  Macrolide Resistance in the Syphilis Spirochete, Treponema pallidum ssp. pallidum: Can We Also Expect Macrolide-Resistant Yaws Strains?

Authors:  David Šmajs; Lenka Paštěková; Linda Grillová
Journal:  Am J Trop Med Hyg       Date:  2015-07-27       Impact factor: 2.345

3.  Cefotaxime in the treatment of female pelvic soft tissue infections.

Authors:  S Roy; J Wilkins
Journal:  Infection       Date:  1985       Impact factor: 3.553

4.  Sex-associated Risk Factors for Co-infection with Chlamydia trachomatis and Neisseria gonorrhoea among Patients Presenting to a Sexually Transmitted Infection Clinic.

Authors:  Farnam Barati Sedeh; Simon F Thomsen; Helle K Larsen; Henrik Westh; Kirsten Salado-Rasmussen
Journal:  Acta Derm Venereol       Date:  2021-01-04       Impact factor: 3.875

5.  Ampicillin/Sulbactam vs. Cefoxitin for the treatment of pelvic inflammatory disease.

Authors:  J G Jemsek; F Harrison
Journal:  Infect Dis Obstet Gynecol       Date:  1997

6.  Inpatient treatment for uncomplicated and complicated acute pelvic inflammatory disease: ampicillin/sulbactam vs. Cefoxitin.

Authors:  D L Hemsell; G D Wendel; P G Hemsell; M L Heard; B J Nobles
Journal:  Infect Dis Obstet Gynecol       Date:  1993
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.